ASML vs TXMD · P/E 57, $665.37B cap vs rev $1.8M
ASML Holding NV ADR (ASML) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the ASML and TXMD stock pages for the full models.
Not investment advice.